PRESS RELEASE published on 06/10/2025 at 09:59, 5 months 25 days ago Virbac : Declaration of the number of share and voting rights 05/2025 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,705,976. Total shares: 8,390,660 as of May 31, 2025 Euronext Paris Voting Rights Shares Financial Market VIRBAC
BRIEF published on 05/26/2025 at 10:10, 6 months 9 days ago Terms and conditions of the VIRBAC General Assembly Documents Shareholder Vote General Assembly VIRBAC Video Broadcast
BRIEF published on 03/13/2025 at 18:50, 8 months 22 days ago Virbac publishes its consolidated accounts for 2024 Financial Audit 2024 Financial Transparency Consolidated Accounts VIRBAC
PRESS RELEASE published on 03/13/2025 at 18:45, 8 months 22 days ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2024
BRIEF published on 10/17/2024 at 17:50, 1 year 1 month ago Virbac: Positive financial results at the end of September Strategic Acquisitions Financial Growth VIRBAC 2024 Results Animal Market
BRIEF published on 10/03/2024 at 12:07, 1 year 2 months ago Virbac: Declaration on Shares and Voting Rights Euronext Paris Voting Rights Actions Financial Transparency VIRBAC
PRESS RELEASE published on 10/03/2024 at 12:02, 1 year 2 months ago Virbac : Declaration of the number of shares and voting rights 09/2024 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris, with total voting rights of 12,708,271 and total shares representing the share capital of 8,390,660 as of September 30, 2024 Euronext Paris Voting Rights Shares Financial Market VIRBAC
BRIEF published on 09/16/2024 at 14:05, 1 year 2 months ago Virbac corrects the amount of its share capital Share Capital Press Release Animal Health Correction VIRBAC
BRIEF published on 09/13/2024 at 17:50, 1 year 2 months ago Virbac announces the conditions of Sébastien Huron's departure Resignation Remuneration VIRBAC Sebastian Huron Non-competition Clause
PRESS RELEASE published on 09/13/2024 at 17:45, 1 year 2 months ago Virbac : the board of directors announces a capital reduction through cancellation of treasury shares Virbac's board of directors announces a capital reduction by canceling 67,340 treasury shares. Dick family group now holds 50.09% of share capital and 66.20% of voting rights Treasury Shares Shareholder Structure Capital Reduction VIRBAC Dick Family Group
Published on 12/05/2025 at 02:35, 7 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 21 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 31 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 56 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 1 minute ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 16 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 17 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
